author-photo

Christian Marinaccio

Northwestern University

13

Papers

157

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

LKB1/STK11 is a tumor suppressor in the progression of myeloproliferative neoplasms.

2021 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (8)
Epigenetic reprogramming of host and viral genes by Human Cytomegalovirus infection in Kasumi-3 myeloid progenitor cells at early times post-infection.

2021 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (1)
Loss of LKB1/STK11 Facilitates Leukemic Progression of the Myeloproliferative Neoplasms

2020 Blood
Show All
- Source
- Cite
- Save
Citations (2)
FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome.

2020 Blood Cancer Journal
Show All
- Source
- Cite
- Save
Citations (6)
Activation of JAK/STAT signaling in megakaryocytes sustains myeloproliferation in vivo

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (26)
GATA ‐1: A potential novel biomarker for the differentiation of essential thrombocythemia and myelofibrosis

2019 Journal of Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (3)
Constitutively photomorphogenic 1 reduces the sensitivity of chronic lymphocytic leukemia cells to fludarabine through promotion of ubiquitin-mediated P53 degradation

2018 Cellular Physiology and Biochemistry
Show All
- Source
- Cite
- Save
Citations (3)
Alisertib (MLN8237), an Oral Selective Inhibitor of Aurora Kinase a, Has Clinical Activity and Restores GATA1 Expression in Patients with Myelofibrosis

2018 Blood
Show All
- Source
- Cite
- Save
Citations (6)
A Multicenter, Open-Label, Pilot Study of Alisertib (MLN8237), a Novel Inhibitor of Aurora Kinase a, in Myelofibrosis

2017 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis

2017 Journal of Clinical Investigation
Show All
- Source
- Cite
- Save
Citations (47)